Validation of the FASD‐Tree as a screening tool for fetal alcohol spectrum disorders
Alcohol: Clinical and Experimental Research · 2023
DOI: 10.1111/acer.14987 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcohol: Clinical and Experimental Research, 2023. Verfasst von Sarah N Mattson und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Behavioral Teratology and Department of Psychology, San Diego State University, San Diego, California, USA. Hauptthemen laut MEDLINE: Fetal Alcohol Spectrum Disorders, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.
Abstract (Originalsprache)
Background
As many as 80% of individuals with fetal alcohol spectrum disorders (FASD) are misdiagnosed or not diagnosed. This study tests the accuracy and validity of a web‐based screening tool (the FASD‐Tree) for identifying children and adolescents with FASD.
Methods
Children with histories of prenatal alcohol exposure (PAE) and controls ( N = 302, including 224 with PAE and 78 controls) were examined for physical signs of fetal alcohol syndrome (FAS), and parents completed behavioral questionnaires. Data were entered into the FASD‐Tree, a web‐based decision tree application. The FASD‐Tree provided two outcomes: a dichotomous indicator (yes/no) and a numeric risk score (0 to 5), which have been shown separately to identify children with PAE and neurobehavioral impairment and to correlate with neurobehavioral outcomes. Overall accuracy (ACC), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for the decision tree, risk score, and their combination. Misclassified cases were examined for systematic bias.
Results
The FASD‐Tree was successful in accurately identifying youth with histories of PAE and the subgroup of individuals with FASD, indicating its validity as an FASD screening tool. Overall accuracy rates for FASD‐Tree components ranged from 75.0% to 84.1%, and both the decision tree outcome and risk score, and their combination, resulted in fair to good discrimination (area under the curve = 0.722 to 0.862) of youth with histories of PAE or FASD. While most participants were correctly classified, those who were misclassified differed in IQ and attention. Race, ethnicity, and sex did not affect the results.
Conclusion
The FASD‐Tree is not a biomarker of PAE and does not provide definitive evidence of prenatal alcohol exposure. Rather it is an accurate and valid screening tool for FASD and can be used by clinicians who suspect that a patient has a history of PAE, even if the exposure is unknown.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Behavioral Teratology and Department of Psychology, San Diego State University, San Diego, California, USA.
- Department of Pediatrics, School of Medicine, University of California, San Diego, San Diego, California, USA.
- Blue Resonance, LLC, San Diego, California, USA.
- Department of Psychiatry & Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota, USA.
ORCID-Profile: Sarah N Mattson, Natasia S Courchesne-Krak
Förderung
- NIAAA NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Mattson, S. N., Jones, K. L., Chockalingam, G., Wozniak, J. R., Hyland, M. T., Courchesne-Krak, N. S., Del Campo, M., Riley, E. P., & CIFASD (2023). Validation of the FASD‐Tree as a screening tool for fetal alcohol spectrum disorders. Alcohol: Clinical and Experimental Research. https://doi.org/10.1111/acer.14987
Vancouver
Mattson SN, Jones KL, Chockalingam G, Wozniak JR, Hyland MT, Courchesne-Krak NS, et al. Validation of the FASD‐Tree as a screening tool for fetal alcohol spectrum disorders. Alcohol: Clinical and Experimental Research. 2023. doi:10.1111/acer.14987
BibTeX
@article{Mattson2023,
author = {Mattson, Sarah N and Jones, Kenneth Lyons and Chockalingam, Ganz and Wozniak, Jeffrey R and Hyland, Matthew T and Courchesne-Krak, Natasia S and Del Campo, Miguel and Riley, Edward P and CIFASD, CIFASD},
title = {Validation of the FASD‐Tree as a screening tool for fetal alcohol spectrum disorders},
journal = {Alcohol: Clinical and Experimental Research},
year = {2023},
doi = {10.1111/acer.14987}
}
EUVIMED